Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 71,286 | 55,972 | 75,527 | 169,724 | 119,709 |
Marketable Securities | 639,355 | 657,012 | 647,107 | 652,437 | 825,283 |
Receivables | 43,178 | 41,254 | 38,267 | 31,303 | 36,938 |
Inventories | 21,223 | 16,457 | 17,016 | 17,521 | 29,697 |
TOTAL | $808,393 | $808,172 | $811,335 | $900,344 | $1,046,651 |
Non-Current Assets | |||||
PPE Net | 41,959 | 40,619 | 36,957 | 33,741 | 33,344 |
Investments And Advances | 84,319 | 142,031 | 141,721 | 166,939 | 161,269 |
Other Non-Current Assets | 114,579 | 114,477 | 116,432 | 119,346 | 108,638 |
TOTAL | $240,857 | $297,127 | $295,110 | $320,026 | $303,251 |
Total Assets | $1,049,250 | $1,105,299 | $1,106,445 | $1,220,370 | $1,349,902 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 30,278 | 30,221 | 17,857 | 17,382 | 16,851 |
Accounts payable and accrued liabilities | 4,710 | 6,963 | 6,979 | 10,563 | 2,729 |
Accrued Expenses | 127,992 | 110,436 | 101,162 | 108,735 | 131,123 |
Other current liabilities | 39,198 | 35,137 | 28,410 | 21,377 | 17,285 |
TOTAL | $214,923 | $197,384 | $169,028 | $172,684 | $183,234 |
Non-Current Liabilities | |||||
Long Term Debt | 208,535 | 208,157 | 122,146 | 122,130 | 122,232 |
Deferred Revenues | 812 | 3,010 | 3,328 | 3,740 | 4,667 |
Other Non-Current Liabilities | 490,391 | 492,147 | 499,141 | 506,258 | 516,135 |
TOTAL | $703,718 | $705,304 | $626,287 | $633,388 | $651,991 |
Total Liabilities | $918,641 | $902,688 | $795,315 | $806,072 | $835,225 |
Shareholders' Equity | |||||
Shares Outstanding, K | 61,232 | 60,790 | 60,665 | 60,467 | 59,984 |
Common Shares | 61 | 61 | 61 | 60 | 60 |
Retained earnings | -2,339,942 | -2,229,025 | -2,095,311 | -1,962,518 | -1,832,958 |
Other shareholders' equity | -3,495 | -2,683 | -4,221 | -4,602 | -10,443 |
TOTAL | $130,609 | $202,611 | $311,130 | $414,298 | $514,677 |
Total Liabilities And Equity | $1,049,250 | $1,105,299 | $1,106,445 | $1,220,370 | $1,349,902 |